LDLR and familial hyperaldosteronism: Furthermore, to reduce FH-associated morbidities and cardiovascular mortality, we suggest that patients with LDLR rs28942084 polymorphism should be closely monitored to track serum LDL and total cholesterol levels, since a causal relationship between increased lipoprotein levels and risk of AMI has been proven.